Literature DB >> 29514117

Measuring costs of community mental health care in Italy: A prevalence-based study.

F Senese1, P Rucci2, M P Fantini3, D Gibertoni3, E Semrov4, M Nassisi4, R Messina3, C Travaglini5.   

Abstract

BACKGROUND: Information on individual mental healthcare costs and utilization patterns in Italy is scant. We analysed the use and the annual costs of community mental health services (MHS) in an Italian local health authority (LHA). Our aims are to compare the characteristics of patients in the top decile of costs with those of the remaining 90%, and to investigate the demographic and clinical determinants of costs.
METHODS: This retrospective study is based on administrative data of adult patients with at least one contact with MHS in 2013. Costs of services were estimated using a microcosting method. We defined as high cost (HC) those patients whose community mental health services costs place them in the top decile of the cost distribution. The predictors of costs were investigated using multiple linear regression.
RESULTS: The overall costs borne for 7601 patients were 17 million €, with HC accounting for 87% of costs and 73% of services. Compared with the rest of the patients, HC were younger, more likely to be male, to have a diagnosis of psychosis, and longer and more intensive MHS utilization. In multiple linear regression, younger age, longer duration of contact with MHS, psychosis, bipolar disorder, personality disorder, depression, dementia and Italian citizenship accounted for 20.7% of cost variance.
CONCLUSION: Direct mental health costs are concentrated among a small fraction of patients who receive intensive socio-rehabilitation in community services. One limitation includes the unavailability of hospital costs. Our methodology is replicable and useful for national and cross-national benchmarking.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Community mental health services; Direct costs; Mental health costs; Psychosis

Mesh:

Year:  2018        PMID: 29514117     DOI: 10.1016/j.eurpsy.2018.02.001

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  3 in total

1.  The Incidence and Costs of Adverse Events Associated with Antidepressants: Results from a Systematic Review, Network Meta-Analysis and Multi-Country Economic Model.

Authors:  Benjamin Kearns; Katy Cooper; Martin Orr; Munira Essat; Jean Hamilton; Anna Cantrell
Journal:  Neuropsychiatr Dis Treat       Date:  2022-06-07       Impact factor: 2.989

2.  Healthcare Costs for People with Serious Mental Illness in England: An Analysis of Costs Across Primary Care, Hospital Care, and Specialist Mental Healthcare.

Authors:  Jemimah Ride; Panagiotis Kasteridis; Nils Gutacker; Maria Jose Aragon Aragon; Rowena Jacobs
Journal:  Appl Health Econ Health Policy       Date:  2020-04       Impact factor: 2.561

3.  Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study.

Authors:  Rossella Messina; Marica Iommi; Paola Rucci; Chiara Reno; Maria Pia Fantini; Carlotta Lunghi; Mattia Altini; Francesca Bravi; Simona Rosa; Antonio Nicolucci; Paolo Di Bartolo
Journal:  Acta Diabetol       Date:  2021-09-08       Impact factor: 4.280

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.